Medable, a leading technology platform for agentic AI-powered clinical development, has announced its Agentic accelerator programme to help life sciences companies transform clinical development with agentic AI.
The programme includes onboarding, integration support, governance, and change management to enable sponsors and contract research organizations to gain value from AI agents on day one.
Surprisingly, only 22% of life sciences leaders have scaled AI across the enterprise and far fewer have transformed clinical development. As AI capabilities continue to evolve rapidly, companies need hands-on partners who provide both strategic guidance and a path to immediate impact and return on investment (ROI).
Medable’s Agentic accelerator programme dramatically improves time to value by providing strategic guidance and a clear path to implementation and scale.
The programme supports customers with a dedicated team of AI clinical development experts and forward-deployed engineers (FDEs), ensuring that customers can move quickly on standard agentic use cases while also developing proprietary workflows and agentic solutions on the Medable platform.
